BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26739150)

  • 1. Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer.
    Fagotti A; Perelli F; Pedone L; Scambia G
    Curr Treat Options Oncol; 2016 Jan; 17(1):3. PubMed ID: 26739150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of minimally invasive interval debulking surgery in advanced epithelial ovarian cancer.
    Menderes G; Black JD; Azodi M
    Expert Rev Anticancer Ther; 2016 Sep; 16(9):899-901. PubMed ID: 27477495
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of minimally invasive surgery in ovarian cancer.
    Nezhat FR; Pejovic T; Finger TN; Khalil SS
    J Minim Invasive Gynecol; 2013; 20(6):754-65. PubMed ID: 24183269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
    Favero G; Macerox N; Pfiffer T; Köhler C; da Costa Miranda V; Estevez Diz Mdel P; Fukushima JT; Baracat EC; Carvalho JP
    Oncology; 2015; 89(3):159-66. PubMed ID: 25968072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
    Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
    Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for minimally invasive surgery for ovarian cancer.
    Han ES; Wakabayashi M
    J Natl Compr Canc Netw; 2011 Jan; 9(1):126-32. PubMed ID: 21233249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advanced ovarian cancer: primary debulking (PDS) or neoadjuvant chemotherapy (NACT) - still a debate].
    Segev Y; Gemer O; Auslender R; Lavie O
    Harefuah; 2014 Sep; 153(9):527-31, 558. PubMed ID: 25417489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally invasive interval cytoreductive surgery in ovarian cancer: systematic review and meta-analysis.
    Cardenas-Goicoechea J; Wang Y; McGorray S; Saleem MD; Carbajal Mamani SL; Pomputius AF; Markham MJ; Castagno JC
    J Robot Surg; 2019 Feb; 13(1):23-33. PubMed ID: 29992404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Minimally Invasive Surgery in the Care of Women with Ovarian Cancer: A Systematic Review and Meta-analysis.
    Knisely A; Gamble CR; St Clair CM; Hou JY; Khoury-Collado F; Gockley AA; Wright JD; Melamed A
    J Minim Invasive Gynecol; 2021 Mar; 28(3):537-543. PubMed ID: 33202311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
    Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial.
    Costales AB; Crane EK; Chambers L; Yao M; Chau D; Naumann WR; Debernardo R; Ricci S; Rose PG; Michener CM
    Gynecol Oncol; 2024 Jun; 185():143-147. PubMed ID: 38417209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary debulking surgery of the upper abdomen and the diaphragm, with a plasma device surgery system, for advanced ovarian cancer.
    Cordeiro Vidal G; Babin G; Querleu D; Guyon F
    Gynecol Oncol; 2017 Jan; 144(1):223-224. PubMed ID: 27836207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
    Vergote IB; De Wever I; Decloedt J; Tjalma W; Van Gramberen M; van Dam P
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):31-6. PubMed ID: 10952124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of minimally invasive surgery in epithelial ovarian cancer treatment: a narrative review.
    Generali M; Annunziata G; Pirillo D; D'Ippolito G; Ciarlini G; Aguzzoli L; Mandato VD
    Front Med (Lausanne); 2023; 10():1196496. PubMed ID: 37387787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of hand-assisted laparoscopy in ovarian cancer.
    Krivak TC; Elkas JC; Rose GS; Sundborg M; Winter WE; Carlson J; MacKoul PJ
    Gynecol Oncol; 2005 Jan; 96(1):72-6. PubMed ID: 15589583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robotic surgery in ovarian cancer.
    Gallotta V; Certelli C; Oliva R; Rosati A; Federico A; Loverro M; Lodoli C; Foschi N; Lathouras K; Fagotti A; Scambia G
    Best Pract Res Clin Obstet Gynaecol; 2023 Aug; 90():102391. PubMed ID: 37573801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram to predict feasibility of minimally invasive interval debulking surgery in advanced ovarian cancer.
    Conte C; Rosati A; Marchetti C; Iacobelli V; Quagliozzi L; Gallucci V; Gueli Alletti S; Scambia G; Fagotti A
    Int J Gynecol Cancer; 2022 Apr; 32(4):532-539. PubMed ID: 35022309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of minimally invasive surgery in staging of ovarian cancer.
    Iglesias DA; Ramirez PT
    Curr Treat Options Oncol; 2011 Sep; 12(3):217-29. PubMed ID: 21503633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary debulking surgery versus neo-adjuvant chemotherapy in stage III/IV ovarian cancer: Comparison of perioperative morbidity and survival data in Pakistani women.
    Chishti U; Aziz AB
    J Pak Med Assoc; 2015 Mar; 65(3):306-9. PubMed ID: 25933567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical cytoreduction in ovarian cancer.
    McCreath WA; Chi DS
    Oncology (Williston Park); 2004 May; 18(5):645-53, discussion 653-4, 656, 658. PubMed ID: 15209191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.